Beam Therapeutics (BEAM) Other Working Capital Changes (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Other Working Capital Changes data on file, last reported at -$6.4 million in Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 7040.45% year-over-year to -$6.4 million in Q1 2026; TTM through Mar 2026 was -$19.8 million, a 222.53% decrease from a year earlier, with the FY2025 full-year figure at -$13.5 million, down 4.28% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$6.4 million, down from $8.1 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for BEAM reached as high as $31.9 million in Q1 2026 and fell as low as -$6.2 million in Q2 2024.
• Historically, Other Working Capital Changes has averaged $2.8 million across 5 years, with a median of -$49000.0 in 2025.
• Across the five-year window, Other Working Capital Changes soared 138366.67% in 2022 and sank 7040.45% in 2026, its largest moves.
• Year by year, Other Working Capital Changes stood at -$1.1 million in 2022, then jumped by 4776.17% to $49.8 million in 2023, then plunged by 106.57% to -$3.3 million in 2024, then surged by 347.08% to $8.1 million in 2025, then sank by 178.53% to -$6.4 million in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$6.4 million in Q1 2026, $8.1 million in Q4 2025, and -$5.7 million in Q3 2025.